Kaliumjodid G.L. (Potassium Iodide)

Potassium iodide works by delivering a large amount of stable iodine to the thyroid gland. This saturates the gland and competitively inhibits the uptake of radioactive iodine isotopes, preventing their incorporation into thyroid tissue. The result is a reduced radiation dose to the thyroid during nuclear incidents or medical procedures involving radioactive iodine.

The appropriate dose of Kaliumjodid G.L. is determined by a qualified prescriber based on the specific indication, patient age, weight, and exposure risk. Healthcare professionals calculate the regimen to ensure effective thyroid protection while minimizing potential side effects.

Safety of potassium iodide during pregnancy or lactation should be evaluated by a healthcare professional. While adequate iodine is essential for fetal development, excess iodine may affect thyroid function. Pregnant or breastfeeding individuals should discuss potential benefits and risks with their physician before using Kaliumjodid G.L.

To order Kaliumjodid G.L., submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide. After submission, the sales team will verify trade or institutional credentials and respond with pricing, availability, shipping details, and any necessary import documentation.

Kaliumjodid G.L. provides pharmaceutical‑grade potassium iodide specifically formulated for rapid thyroid saturation, making it suitable for radioprotective use. Over‑the‑counter iodine supplements often contain lower, nutritional doses intended for daily dietary support and may not achieve the rapid saturation needed in emergency radiation scenarios.

Kaliumjodid G.L. should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the product from moisture, direct sunlight, and extreme temperatures to maintain stability. Keep out of reach of children and ensure the container is tightly closed when not in use.

Kaliumjodid G.L. is administered orally, typically as a tablet or liquid preparation, as directed by a healthcare professional. The product should be taken with water and according to the prescribed schedule to achieve optimal thyroid saturation before or during exposure to radioactive iodine.

Serious risks, though rare, include allergic reactions such as rash, urticaria, or anaphylaxis, and iodine‑induced thyroid dysfunction (hyperthyroidism or hypothyroidism). Individuals with pre‑existing thyroid disorders, lithium therapy, or antithyroid medication should be monitored closely for these potential complications.

Kaliumjodid G.L. should be avoided in individuals with known hypersensitivity to potassium iodide or any component of the formulation. Patients receiving antithyroid drugs, lithium, or amiodarone should consult a physician before use, as concurrent therapy may require adjustment or monitoring.